Bright Minds Biosciences(DRUG.US)

Last Updated 19:00:00 ET
longbridge loading

Psychedelic Stocks Just Went Mainstream

ZeroHedge·
US
GHRS
-2.40%
US
ATAI
+4.69%
US
DRUG
-0.68%
ZeroHedge·
US
GHRS
-2.40%
US
ATAI
+4.69%
US
DRUG
-0.68%

Psychedelic drug stocks are surging after Trump's order to fast-track development for medical use

businessinsider·
US
CMPS
+9.11%
US
SILO
+4.05%
US
HELP
+5.07%
businessinsider·
US
CMPS
+9.11%
US
SILO
+4.05%
US
HELP
+5.07%

Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from BTIG Research

Market Beat·
US
VHT
+0.04%
US
LABU
-0.89%
US
DRUG
-0.68%
Market Beat·
US
VHT
+0.04%
US
LABU
-0.89%
US
DRUG
-0.68%

Havas Health and BrightInsight Forge Exclusive Alliance to Tackle Pharma's $500B+ Patient Problem

fidelity·
US
BBH
+0.32%
SZ
159316
+1.61%
SH
513060
+0.57%
fidelity·
US
BBH
+0.32%
SZ
159316
+1.61%
SH
513060
+0.57%

Canadian Securities Exchange Reports January 2026 Performance Figures

Newsfile Corp.·
US
DRUG
-0.68%
Newsfile Corp.·
US
DRUG
-0.68%

De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 Franchise

Tip Ranks·
US
IBB
-0.03%
US
DRUG
-0.68%
US
SBIO
+0.78%
Tip Ranks·
US
IBB
-0.03%
US
DRUG
-0.68%
US
SBIO
+0.78%

Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Rises By 67.5%

Market Beat·
US
XLV
+0.08%
US
PBE
-0.14%
US
XBI
-0.20%
Market Beat·
US
XLV
+0.08%
US
PBE
-0.14%
US
XBI
-0.20%

Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Market Beat·
US
DRUG
-0.68%
Market Beat·
US
DRUG
-0.68%

Bright Minds Biosciences (NASDAQ:DRUG) Cut to "Sell" at Wall Street Zen

Market Beat·
US
DRUG
-0.68%
Market Beat·
US
DRUG
-0.68%

Bright Minds Biosciences Announces Closing of US$175 Million Public Offering | DRUG Stock News

StockTitan·
US
DRUG
-0.68%
StockTitan·
US
DRUG
-0.68%
© 2026 Longbridge｜Disclaimer